Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).
REVOLUTION Medicines
19 followers
Summit Therapeutics
8 followers
Kymera Therapeutics
7 followers
Celldex Therapeutics
4 followers
Arcutis Biotherapeutics
3 followers
Biosynth
3 followers
Scholar Rock
1 follower
Olema Oncology
1 follower
Provivi
1 follower
Pharmacosmos
3 followers
Repertoire Immune Medicines
3 followers
Alloy Therapeutics
2 followers